InsidersTradesSigma
Follow the CLEARPOINT NEURO INC stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €474.3m. The latest transaction was disclosed on 29 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOSEPH BURNETT. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
CLEARPOINT NEURO INC es una empresa centrada en el desarrollo de tecnologías de navegación quirúrgica para el tratamiento de trastornos neurológicos. Su objetivo es mejorar los resultados clínicos a través de soluciones innovadoras.